PlainDoctor

2026 NPPES data Hematology & Oncology Physician NPI 1487035242 M.D.
Verify on CMS →

Sherwin Desouza, M.D.

Hematology & Oncology Physician in Indianapolis, Indiana.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
207
Medicare Part D claims · 61 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
40%
generic claims · 60% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
79.5/100
▼ 4 pts below national avg 83.5 · Above neutral
Industry payments
$5.9K
28 payments · CMS Open Payments (Sunshine Act)
Verify NPI on CMS Methodology
Compiled from official public sources by the editorial process.

What the federal data shows

Sherwin Desouza, M.D. reported a CMS MIPS final score of 79.5/100 - below the 83.5 national average - and filed 207 Medicare Part D claims in 2024.

79.5/100
MIPS score · -4 vs avg
207
Part D claims, 2024
40%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Sherwin Desouza, M.D.

Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1487035242), first enumerated 06/17/2015.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 207 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    Reported a CMS MIPS final score of 79.5/100 in the Quality Payment Program — a federal quality measure, not a patient review.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    4 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $5.9K in reported industry payments (28 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1487035242 · Hematology & Oncology Physician

NPI-10 · ENUM-MID · TAX-MID · MIPS-BELOW · RX-LIGHT · BOOK-THIN · PHOTO-FINISH

  • NPI-10 1487035242
  • ENUM-MID 2015
  • TAX-MID 12K Hematology &
  • MIPS-BELOW 79.5/100
  • RX-LIGHT 207
  • BOOK-THIN 176 in Indiana
  • PHOTO-FINISH Puja Arora · ±0.0

MIPS final-score neighbourhood

Same-specialty nationwide peers by CMS final score, not geographic proximity

MIPS pts

What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).

Source CMS Quality Payment Program (MIPS) As of 2023

Sherwin Desouza, M.D.'s MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

80 ≥ 26th percentile 26% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). Below this entry. 10–20: 3,008 measured providers (1%). Below this entry. 20–30: 3,069 measured providers (1%). Below this entry. 30–40: 2,746 measured providers (1%). Below this entry. 40–50: 2,928 measured providers (1%). Below this entry. 50–60: 5,882 measured providers (1%). Below this entry. 60–70: 13,906 measured providers (3%). Below this entry. 70–80: 94,570 measured providers (21%). This entry sits in this band. 80–90: 129,887 measured providers (29%). Above this entry. 90+: 189,403 measured providers (42%). Above this entry. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Sherwin Desouza, M.D. sits

This provider among hematology & oncology physician peers

Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Sherwin Desouza, M.D. writes more Part D claims than 17% of them and scores higher on MIPS quality than 26% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.148.372.496.6Part D claim volume, percentile in specialtyMIPS quality, percentilePoint, Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 7Point, Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 63Point, Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 78Point, Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 22Point, Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 60Point, Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 73Point, Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 23Point, Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 35Point, Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 57Point, Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 30Point, Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 8Point, Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 75Point, Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 2Point, Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 33Point, Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 90Point, Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 83Point, Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 37Point, Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 38Point, Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 18Point, Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 72Point, Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 82Point, Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 87Point, Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 67Point, Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 13Point, Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 3Point, Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 77Point, Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 15Point, Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 28Point, Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 52Point, Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 70Point, Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 10Point, Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 58Point, Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 10Point, Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 5Point, Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 43Point, Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 85Point, Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 18Point, Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 32Point, Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 65Point, Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 62Point, Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 27Point, Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 68Sherwin Desouza, M.D., Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 26
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Sherwin Desouza, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

✓
Board certification likely (heuristic, not verified)

Sherwin Desouza, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 4 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Sherwin Desouza, M.D.?

Near national average

NPI registry status

Active

Issued 06/17/2015

NPI 1487035242

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,530 US NPIs in this specialty

Medicare Part D claims

207 77% vs specialty avg

2024 prescription claims

Specialty avg: 885

MIPS final score

79.5/100 4 pts vs avg

Above neutral band

vs 83.5 national avg

Specialty distribution in Indiana

How Hematology & Oncology Physician compares to other specialties among Indiana providers

Indiana providers
Behavior Technician14.3%Student in an Organized Heal…4.8%Pharmacist4.3%Clinical Social Worker4.2%Family Nurse Practitioner4.2%Mental Health Counselor4.1%Hematology & Oncology Physic…0.1%
Largest specialties in Indiana (% of in-state providers)

Medicare quality performance, MIPS

Sherwin Desouza, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Near national average
MIPS Final Score
79.5/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%79.5%
MIPS final score (Hematology & Oncology Physician) - 79.5/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

8326 NAAB RD
Indianapolis, IN 46260
(317) 871-0011

Provider Details

NPI 1487035242
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 06/17/2015

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

79.4829
Final Score
Measured-score avg: 83.5
68.5144
Quality
63.0952
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Sherwin Desouza, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

According to CMS billing records, Sherwin Desouza, M.D. is affiliated with 4 Medicare-billing facilities across 2 states.

Indiana Hemophilia And Thrombosis Center, Inc.
Indianapolis, IN
Innovative Hematology Inc
Indianapolis, IN
IU Health Medical Group LLC
Indianapolis, IN
University Hospitals Medical Group Inc
Cleveland, OH

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Sherwin Desouza, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$5.9K

Largest payer

GENZYME CORPORATION

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

Sherwin Desouza, M.D. - brand share 60.0%
Hematology & Oncology Physician average

60% brand-name claims vs 40% generic, on 207 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

207
Total Claims
$605K
Total Drug Cost
61
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
401.367
Total Day Supply
11,560
Brand vs Generic
60% brand / 40% generic
Brand Drug Cost
$587K
Generic Drug Cost
$18K

Patient Demographics

Average Patient Age
75.6 years
Avg HCC Risk Score
2.24
Gender Split
64% female / 36% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Sherwin Desouza, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Eliquis
Apixaban
89
Hydroxyurea
 27
Enoxaparin Sodium
 13
Xarelto
Rivaroxaban
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

More Hematology & Oncology Physician in IN → All providers in Indiana → Compare specialties →

Hematology & Oncology Physician Overview

How Sherwin Desouza, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider

Sherwin Desouza, M.D.'s 207 claims are below the specialty average of 885.

Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Desouza, both outside Indiana so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (79.5 here).

Puja Arora 79.5 DC David Bajor 79.5 OH Pedro Barata 79.5 LA Jason Brown 79.5 MI

Same NPPES enumeration year (2015)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Daniel Chakos Hinsdale, IL Vijendra Singh Detroit, MI Manisha Bhattacharya Pittsburgh, PA Meytal Fabrikant Port Jefferson Station, NY

Nearby Hematology & Oncology Physician Providers in Indiana

Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Desouza.

One of 176 Hematology & Oncology Physician providers enrolled in Indiana, 5 are shown here.

Dr. Mohammad Abu Zaid
M.D.
Kokomo, IN
Dr. Farrukh Adhami
MD
Fort Wayne, IN
Dr. Nabil Adra
MD
Indianapolis, IN
Dr. Lakshmi Aggarwal
MD
Fort Wayne, IN
Dr. Maqbool Ahmed
M.D.
Evansville, IN

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Sherwin Desouza, M.D.'s specialty? ▼
Sherwin Desouza, M.D. specializes in Hematology & Oncology Physician and practices in Indianapolis, Indiana. Credentials: M.D..
How much does Sherwin Desouza, M.D. prescribe under Medicare Part D? ▼
In 2024, Sherwin Desouza, M.D. wrote 207 Medicare Part D claims totaling $605K in drug costs for 61 beneficiaries.
What is Sherwin Desouza, M.D.'s Medicare quality score? ▼
Sherwin Desouza, M.D. has a CMS MIPS Final Score of 79.5/100 (Quality: 68.5, Cost: 63.1). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Sherwin Desouza, M.D. located? ▼
Sherwin Desouza, M.D. is located at 8326 NAAB RD, Indianapolis, IN, 46260. Phone: (317) 871-0011.
What is Sherwin Desouza, M.D.'s NPI number? ▼
Sherwin Desouza, M.D.'s National Provider Identifier (NPI) is 1487035242, issued on 06/17/2015.
Does Sherwin Desouza, M.D. prescribe more brand-name or generic drugs? ▼
Sherwin Desouza, M.D.'s prescribing is 60% brand-name and 40% generic drugs by claim count, with $587K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Sherwin Desouza, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Sherwin Desouza, M.D.'s most frequently prescribed drugs include Eliquis, Hydroxyurea, Enoxaparin Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Sherwin Desouza, M.D. accept Medicare? ▼
Sherwin Desouza, M.D. appears in CMS Medicare data with 207 Part D claims and 61 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Sherwin Desouza, M.D.'s credentials? ▼
Sherwin Desouza, M.D.'s NPI is 1487035242 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the editorial process.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.